NANOPSY
NanoPsy is a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy. Our patented nano technology which, in combination with our targeted delivery and controlled dosing technology methods, will allow for an increase in solubility/absorption of these molecules. Thus a more efficacious API.
NANOPSY
Industry:
Biotechnology Medical Medical Device
Founded:
2009-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Status:
Active
Total Funding:
500 K CAD
Similar Organizations
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ambria Capital
Ambria Capital investment in Seed Round - NanoPsy
Negev Capital
Negev Capital investment in Seed Round - NanoPsy